Investment Summary

GIMV Invests In ARS T&TT

On July 31, 2012, private equity firm GIMV invested in information technology company ARS T&TT

Investment Highlights
  • This is GIMV’s 4th transaction in the Information Technology sector.
  • This is GIMV’s 22nd transaction in the Netherlands.

Investment Summary

Date 2012-07-31
Target ARS T&TT
Sector Information Technology
Investor(s) GIMV
Deal Type Growth Capital

Target

ARS T&TT

The Hague, Netherlands
ARS T&TT designs, develops, implements, operates and maintains Intelligent Transport Systems (ITS). These integrated solutions include traffic monitoring, traffic management and tolling. ARS T&TT was founded in 1998 and is based in The Hague, Netherlands.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 73 of 170
Sector: Information Technology M&A 4 of 8
Type: Growth Capital M&A Deals 5 of 34
Country: Netherlands M&A 22 of 42
Year: 2012 M&A 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-22 Prosonix

Oxford, United Kingdom

Prosonix is a UK specialty pharmaceutical company focused on the development of a range of product candidates for the treatment of asthma and COPD. Prosonix's portfolio is based on its proprietary particle engineering technology and Prosonitron reactor system, which enables precise control of pharmaceutical product crystallisation during manufacture, and subsequent delivery characteristics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-05 GOVECS

Grunwald, Germany

GOVECS works on the development, production and distribution of electric vehicles. GOVECS was founded in 2009 and is based in Grunwald, Germany.

Buy -